High Content Functional Neuroanatomy of Endogenous GPCRs
内源性 GPCR 的高内涵功能神经解剖学
基本信息
- 批准号:10588941
- 负责人:
- 金额:$ 23.4万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-02-15 至 2025-01-31
- 项目状态:未结题
- 来源:
- 关键词:AccelerationAgonistAnatomyAnimal BehaviorAntibodiesAutoradiographyBehaviorBindingBiochemicalBiological AssayBiosensorBiotinBrainBrain DiseasesChronicChronic stressColorComplexDataDevelopmentDrug usageEquipmentExhibitsFc ReceptorFluorescenceG Protein-Coupled Receptor SignalingG-Protein-Coupled ReceptorsGTP-Binding ProteinsGeneticGoalsHeatingImageImmunohistochemistryIn SituInterventionLigandsLigationLinkLocationMeasurementMeasuresMediatingMetabotropic Glutamate ReceptorsMethodsModelingModificationMolecularMotivationMusNational Institute of Drug AbuseNeuroanatomyNeurosciencesNucleotidesOpioid ReceptorPainPatternPharmaceutical PreparationsPharmacological TreatmentPlayPropertyPublishingRattusReagentResolutionRewardsRoleSensorySignal TransductionSpecificityStressSubstance Use DisorderSynaptic TransmissionSystemTestingTherapeuticTissue FixationTissuesWithdrawaladdictionanatomic imagingbiological adaptation to stresscannabinoid receptorcell typechronic paincryostatdrug of abusedrug seeking behaviorexperimental studyfluorescence microscopeimaging modalityinnovationinsightinterestlaboratory equipmentmu opioid receptorsnegative affectneural circuitneuronal excitabilityneurotransmitter releasenonhuman primatenovelnovel therapeuticsopioid use disorderoptogeneticspharmacologicprotein activationratiometricreceptorreceptor couplingreceptor functionresponsesuccesstemporal measurementtoolvirtual
项目摘要
Abstract
G protein coupled receptors (GPCRs) modulate neuronal excitability and neurotransmitter release, and exert
profound effects on neural circuit functions. They play important roles in regulating motivation, reward, pain,
negative affect, and stress responses, which are all important in the context of substance use disorders
(SUDs). Exogenous ligands for several GPCRs have been shown to modify drug seeking behavior, which has
generated interest in GPCRs as targets for the development of pharmacological therapeutics for substance
use disorders. There are over 300 different non-sensory GPCRs expressed in mammalian brains, and
fundamental questions remain unanswered for all of them. For example, how does a given receptor's ability to
activate different G protein subtypes (Gi/o, Gs, Gq, G12/13) vary across neuroanatomical regions, cell types,
and subcellular regions? How are these properties altered in response to chronic drug use, chronic stress, or
chronic pain? To help answer these questions, we will develop new imaging methods in tissue sections for
neuroanatomical measurement of GPCR-mediated G protein activation, with subcellular resolution and G
protein subtype specificity. Our methods will only require common neuroscience equipment (cryostats and
fluorescence microscopes) and commercially available reagents. They will generate high-content information
on many GPCRs in healthy and diseased brains, and accelerate efforts to target GPCRs in addiction.
抽象的
G 蛋白偶联受体 (GPCR) 调节神经元兴奋性和神经递质释放,并发挥作用
对神经回路功能产生深远影响。它们在调节动机、奖励、痛苦、
负面情绪和压力反应,这些对于药物滥用障碍都很重要
(泡沫)。多种 GPCR 的外源配体已被证明可以改变药物寻求行为,这已被证实
引起了人们对 GPCR 作为药物治疗药物开发靶标的兴趣
使用障碍。哺乳动物大脑中表达了 300 多种不同的非感觉 GPCR,并且
他们所有人的基本问题仍未得到解答。例如,给定受体的能力如何
激活不同的 G 蛋白亚型(Gi/o、Gs、Gq、G12/13)因神经解剖区域、细胞类型、
和亚细胞区域?这些特性如何因长期吸毒、慢性压力或
慢性疼痛?为了帮助回答这些问题,我们将开发新的组织切片成像方法
GPCR 介导的 G 蛋白激活的神经解剖学测量,具有亚细胞分辨率和 G
蛋白质亚型特异性。我们的方法只需要常见的神经科学设备(低温恒温器和
荧光显微镜)和市售试剂。他们将产生高内容的信息
健康和患病大脑中的许多 GPCR,并加速针对成瘾中的 GPCR 的努力。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Patrick Ross O'Neill其他文献
Patrick Ross O'Neill的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Patrick Ross O'Neill', 18)}}的其他基金
Nociceptin receptor signaling and regulation of dopamine transmission in drug reward circuitry
伤害感受肽受体信号传导和药物奖赏回路中多巴胺传递的调节
- 批准号:
10004764 - 财政年份:2017
- 资助金额:
$ 23.4万 - 项目类别:
Nociceptin receptor signaling and regulation of dopamine transmission in drug reward circuitry
伤害感受肽受体信号传导和药物奖赏回路中多巴胺传递的调节
- 批准号:
9164285 - 财政年份:2017
- 资助金额:
$ 23.4万 - 项目类别:
Nociceptin receptor signaling and regulation of dopamine transmission in drug reward circuitry
伤害感受肽受体信号传导和药物奖赏回路中多巴胺传递的调节
- 批准号:
10112864 - 财政年份:2017
- 资助金额:
$ 23.4万 - 项目类别:
Mechanism and role of G-protein subunit translocation in cell signaling
G蛋白亚基易位在细胞信号传导中的机制和作用
- 批准号:
8203869 - 财政年份:2011
- 资助金额:
$ 23.4万 - 项目类别:
Mechanism and role of G-protein subunit translocation in cell signaling
G蛋白亚基易位在细胞信号传导中的机制和作用
- 批准号:
8320558 - 财政年份:2011
- 资助金额:
$ 23.4万 - 项目类别:
Mechanism and role of G-protein subunit translocation in cell signaling
G蛋白亚基易位在细胞信号传导中的机制和作用
- 批准号:
8502709 - 财政年份:2011
- 资助金额:
$ 23.4万 - 项目类别:
相似国自然基金
α7nAChR激动剂通过PGC-1α和HO-1调控肾小管上皮细胞线粒体的质和量进而改善脓毒症急性肾损伤的机制研究
- 批准号:82372172
- 批准年份:2023
- 资助金额:49 万元
- 项目类别:面上项目
基于纳米铝乳剂和模式识别受体激动剂的复合型佐剂研究
- 批准号:82341043
- 批准年份:2023
- 资助金额:110 万元
- 项目类别:专项基金项目
新型IL2Rβγ激动剂逐级控释联合放疗对抗三阴性乳腺癌的作用及机制研究
- 批准号:82303819
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
卡瓦胡椒中选择性大麻素2型受体激动剂的发现及其抗骨质疏松作用研究
- 批准号:82360684
- 批准年份:2023
- 资助金额:32 万元
- 项目类别:地区科学基金项目
脂质纳米粒体内介导嵌合抗原受体-M1型巨噬细胞协同TLR激动剂治疗实体瘤的研究
- 批准号:82304418
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
CD98hc Brain Shuttles for Delivering Off-the-shelf Neuroprotective Antibodies in Alzheimer's Disease
CD98hc 脑穿梭机为阿尔茨海默病提供现成的神经保护抗体
- 批准号:
10566062 - 财政年份:2023
- 资助金额:
$ 23.4万 - 项目类别:
A highly opioid responsive VTA projection to the dorsal endopiriform nucleus.
高度阿片类药物反应的 VTA 投射到背内核状核。
- 批准号:
10739039 - 财政年份:2023
- 资助金额:
$ 23.4万 - 项目类别:
Evaluating a novel, orally-active TREM2-targeting drug in AD
评估一种新型口服活性 TREM2 靶向药物治疗 AD 的效果
- 批准号:
10735206 - 财政年份:2023
- 资助金额:
$ 23.4万 - 项目类别:
Efficient Brain Delivery of Neuroprotective TrkB Agonist Antibodies in Alzheimer’s Disease Using CD98hc Bispecific Shuttles
使用 CD98hc 双特异性穿梭细胞有效脑部递送神经保护性 TrkB 激动剂抗体治疗阿尔茨海默病
- 批准号:
10786022 - 财政年份:2022
- 资助金额:
$ 23.4万 - 项目类别:
Evaluation of 6SHG/EM1 as a treatment for spinal cord injury-induced neuropathic pain in a pig model
6SHG/EM1 治疗猪模型脊髓损伤引起的神经性疼痛的评价
- 批准号:
10935563 - 财政年份:2021
- 资助金额:
$ 23.4万 - 项目类别: